Report Highlights
The U.S. market for assistive technologies is projected to grow from nearly $43.4 billion (including eyeglasses and contact lenses) in 2012 to $45.9 billion in 2013 and nearly $60.5 billion in 2018, a compound annual growth rate (CAGR) of 5.7% between 2013 and 2018.
Report Includes
- An overview of the U.S. market for disabled and elderly assistive technologies, which encompasses a broad range of devices, from "low-tech" products such as eyeglasses and large-print books to technologically sophisticated products such as voice synthesizers, Braille readers, and wireless monitoring devices.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion of market drivers and constraints.
- Examination of the industry structure, competition, and market shares.
- Comprehensive company profiles of major players.
Report Scope
The report focuses on the U.S. market for the various types of devices and products that are on the market or under development to enable disabled and elderly persons to move about, see, hear, speak, dress themselves and perform many other everyday activities as “normally” as possible. Where practical, market developments on the global level are also addressed, although in less detail than domestic market developments.
In the past few years, BCC has published a number of other reports in related areas, such as prosthetics and orthotics, microelectronic medical implants, drugs for the elderly, and antiaging products. The findings and conclusions of these other reports will be cited in this report, where appropriate, for the sake of completeness. However, it is not the author’s intention to duplicate their coverage and analysis; attention will be focused instead on the following:
- Mobility- and dexterity-enhancing products.
- Products for the vision-, hearing-, and speech-impaired.
- Toileting and incontinence products.
- Medical/personal monitoring products.
- Other products such as environmental controls and daily living aids.
This report does not cover physical therapy and exercise equipment designed for the elderly and disabled. The scope of this report also does not include therapeutic treatments such as surgery that are intended to mitigate or eliminate the underlying causes of a particular disability.
In terms of format, the report is divided into the following major sections:
- Technologies used in disabled and elderly care products.
- Conditions and applications addressed.
- Product types.
- Legal, regulatory and insurance issues.
- Patent and intellectual property issues.
- Market size and segmentation.
- Market drivers.
- Market projections from 2012 through 2018.
- Industry size and structure.
- Competition and market shares.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
The U.S. market for assistive technologies is projected to grow from $39.5 billion (including eyeglasses and contact lenses) in 2010 to $41.1 billion in 2011 and $55 billion in 2016, a compound annual growth rate (CAGR) of 6% between 2011 and 2016.
Report Highlights
- The U.S. market for assistive technology is expected to be worth $38.2 billion in 2008, up from $36.4 billion in 2007. This should increase to $49.3 billion in 2013, a compound annual growth rate (CAGR) of 5.3%.
- The vision and reading aids segment dominates the market, generating $24.9 billion in 2007 and an estimated $26.1 billion in 2008 and $33.3 billion in 2013, a CAGR of 5.0%.
- The communication aids segment is worth $4.4 billion in 2007. This should increase slightly in 2008 and reach $5.4 billion in 2013, for a CAGR of 4.0%.
Report Highlights
-
The U.S. market for assistive technologies is projected to rise from $30.7 billion in 2005 to $39.4 billion in 2010, an AAGR (average annual growth rate) of 5.2%.
-
The market excluding eyeglasses and contacts is estimated at $8.7 billion and rising to $11.3 billion in 2010, an AAGR of 5.4%.
-
The largest market segments after vision and reading aids are daily living aids, mobility aids (expected to drop from 7.2% of the market to 5.7% in 2010) and communication aids.
-
Access aids appear poised to increase their market share from 2.9% in 2004 to 4.3% in 2010.
Related Reports
Healthcare Information Technology
The U. S. market for clinical healthcare IT technologies was more than $9.5 billion in 2011 and nearly $11.2 billion in 2012. The market is projected to grow to $26.1 billion in 2017, a compound annual growth rate (CAGR) of 18.5% over the next five years.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics, and surgical equipment was valued at nearly $16.9 billion in 2012, up from $16.2 billion in 2011. The market is expected to reach $20.2 billion in 2017, an increase of nearly $3.4 billion during the forecast period and a compound annual growth rate (CAGR) of 3.7% from 2012 to 2017.
The Global Market for Pain Management Drugs and Devices
The market for pain management drugs and devices was valued at $35.4 billion in 2012. Total market valued is expected to reach $41.5 billion in 2017 after increasing at a five-year compound annual growth rate of 3.2%.
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics was valued at $110 billion in 2011 and should reach nearly $118.7 billion in 2012. Total market value is expected to reach nearly $157 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.7%.
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More